BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Verma V, Choi JI, Simone CB 2nd. Proton therapy for small cell lung cancer. Transl Lung Cancer Res 2018;7:134-40. [PMID: 29876312 DOI: 10.21037/tlcr.2018.04.02] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Huang J, Cao D, Sha J, Zhu X, Han S. DLL3 is regulated by LIN28B and miR-518d-5p and regulates cell proliferation, migration and chemotherapy response in advanced small cell lung cancer. Biochemical and Biophysical Research Communications 2019;514:853-60. [DOI: 10.1016/j.bbrc.2019.04.130] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
2 Miyasaka Y, Sato H, Okano N, Kubo N, Kawamura H, Ohno T. A Promising Treatment Strategy for Lung Cancer: A Combination of Radiotherapy and Immunotherapy. Cancers (Basel) 2021;14:203. [PMID: 35008367 DOI: 10.3390/cancers14010203] [Reference Citation Analysis]
3 Sun Y, Hu B, Wang Y, Li Z, Wu J, Yang Y, Wei Y, Peng X, Chen H, Chen R, Jiang P, Fang S, Yu Z, Guo L. miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins. Cancer Manag Res 2018;10:4735-45. [PMID: 30425570 DOI: 10.2147/CMAR.S178380] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
4 He J, Xu S, Pan H, Li S, He J. Treatments for combined small cell lung cancer patients. Transl Lung Cancer Res 2020;9:1785-94. [PMID: 33209601 DOI: 10.21037/tlcr-20-437] [Reference Citation Analysis]